Vaccination News Home Page            Scandals            subscribe Vaccination NewsLetter

http://jcm.asm.org/cgi/content/abstract/41/5/2258

JCM Email Content Delivery
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]


Full Text of this Article
Reprint (PDF) Version of this Article
Similar articles found in:
JCM Online
PubMed
PubMed Citation
Search Medline for articles by:
McDonald, L. C. || Snyder, J.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Books from ASM Press
 

Journal of Clinical Microbiology, May 2003, p. 2258-2260, Vol. 41, No. 5
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.5.2258-2260.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

 

 

CASE REPORT

 

Peripartum Transmission of Penicillin-Resistant Streptococcus pneumoniae

L. Clifford McDonald,1* Kris Bryant,2 and James Snyder3

Departments of Internal Medicine,1 Pediatrics,2 Pathology, University of Louisville, Louisville, Kentucky3

Received 22 July 2002/ Returned for modification 8 October 2002/ Accepted 10 December 2002

Streptococcus pneumoniae is a rarely recognized cause of neonatal sepsis. We present a recent case of S. pneumoniae bacteremia acquired on the first day of life in a neonate born at 30 weeks of gestation to a mother without prenatal care who had prolonged rupture of the membranes and received intravenous ampicillin prior to delivery. The isolate was resistant to penicillin, with a MIC of the drug of 4 µg/ml. The child responded to a 7-day course of intravenous vancomycin. S. pneumoniae was recovered from the vagina of the mother on a swab culture collected prior to delivery, and isolates from mother and child were confirmed to be identical on the basis of pulsed-field gel electrophoresis. Although neonatal sepsis due to the peripartum transmission of S. pneumoniae is rare, this case highlights the concern that increasing efforts to prevent group B streptococcus neonatal disease may lead to an increase in neonatal infections due to resistant organisms.


* Corresponding author. Mailing address: Centers for Disease Control and Prevention, 1600 Clifton Rd., MS A35, Atlanta, GA 30333. Phone: (404) 639-3833. Fax: (404) 639-2647. E-mail: LJM3@CDC.GOV.

 


Journal of Clinical Microbiology, May 2003, p. 2258-2260, Vol. 41, No. 5
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.5.2258-2260.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.


 


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Diagn. Lab. Immunol.
Clin. Microbiol. Rev. ALL ASM JOURNALS
Copyright © 2003 by the American Society for Microbiology. All rights reserved.

 

Vaccination News Home Page

 

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.